menu
    • menu
    [{"orgOrder":0,"company":"Metro Biotech","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"U.S.A","productType":"Other Small Molecule","year":"2025","type":"Inapplicable","leadProduct":"MIB-725","moa":"p53","graph1":"Nephrology","graph2":"Phase I","graph3":"Metro Biotech","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Oral","sponsorNew":"Metro Biotech \/ Inapplicable","highestDevelopmentStatusID":"6","companyTruncated":"Metro Biotech \/ Inapplicable"}]

    Find Clinical Drug Pipeline Developments & Deals by Metro Biotech

    Menu

    Metro Biotech

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Metro Biotech

                            U.S.A arrow
                            China Battery Fair
                            Not Confirmed

                            Metro Biotech

                            U.S.A arrow
                            China Battery Fair
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : MIB-725

                            Therapeutic Area : Nephrology

                            Study Phase : Phase I

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Metro Biotech Begins Dosing in Phase 1a Trial of NAD Booster MIB-725

                            Details : MIB-725 is the second MetroBiotech therapeutic candidate that targets diseases of aging such as kidney disease, neurodegenerative disease, and muscle disorders.

                            Product Name : MIB-725

                            Product Type : Other Small Molecule

                            Upfront Cash : Inapplicable

                            April 22, 2025

                            Lead Product(s) : MIB-725

                            Therapeutic Area : Nephrology

                            Highest Development Status : Phase I

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth